Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study

被引:23
作者
Geraci, G. [1 ]
Palumbo, V. D. [1 ]
D'Orazio, B. [1 ]
Maffongelli, A. [1 ]
Fazzotta, S. [1 ]
Lo Monte, A., I [1 ]
机构
[1] Univ Teaching Hosp Paolo Giaccone Palermo, Sect Gen & Thorac Surg, Palermo, Italy
来源
CLINICA TERAPEUTICA | 2019年 / 170卷 / 05期
关键词
Diclofenac; ERCP; pancreatitis; complication; prevention; COMPLICATIONS;
D O I
10.7417/CT.2019.2156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Post-Endoscopic Retrograde Cholangio-Pancreatography pancreatitis (PEP) is a relevant (1-4%) complication of biliopancreatic operative endoscopy. Rectal nonsteroidal anti-inflammatory drugs (specifically, 100 mg of diclofenac) have shown promising prophylactic activity in PEP. The aim of our prospective study is to report whether prophylactic oral versus rectal suppository versus intramuscular diclofenac versus placebo are able to reduce the incidence and the severity of ERCP-induced pancreatitis. Materials and Methods. in this randomized, double-blinded, prospective study, 100 patients (49 male, 51 female), similar with regard to indication for ERCP, were enrolled between January 2016 and November 2017 to undergo ERCP in the Section of General and Thoracic Surgery of University Hospital of Palermo. They were randomized into five groups, respectively 20 patients with placebo by mouth; 20 patients with 50 mg diclofenac sodium enteric-coated capsules by mouth; 20 with 100 mg rectal suppository diclofenac, 20 with 75 mg/3 ml intramuscular diclofenac sodium, 20 with 75 mg/3 ml intramuscular diclofenac sodium and 20 with 75 mg/3 ml intravenous diclofenac. All drugs were administered 30 to 90 minutes before ERCP. All clinical data were collected one day before and 2, 12 and 24 hour after ERCP. Results. data were prospectively collected and to demonstrate the preventive effect of rectal diclofenac on PEP, a two-by-two table and chi-square test with Yates correction were used: the incidence of PEP was significantly lower (p < 0.001) in the rectal diclofenac group respect to other groups and, in the same way. the incidence of post-ERCP pain was significantly lower in the rectal diclofenac group than in the other groups (p = 0.001) and patients discharge was consequently earlier (p < 0.01). Conclusions. 100 mg dose rectal diclofenac administered 30-60 minutes before ERCP can effectively prevent PEP.
引用
收藏
页码:E332 / E336
页数:5
相关论文
共 50 条
  • [1] Post-endoscopic retrograde cholangio-pancreatography pancreatitis: Is time for a new preventive approach?
    Tammaro, Stella
    Caruso, Roberta
    Pallone, Francesco
    Monteleone, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (34) : 4635 - 4638
  • [2] Post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) Complications: Our Experience and Comparison with the Literature
    Gozel, Sedat
    Yildiz, Ihsan
    Koca, Yavuz Savas
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7 (05) : 656 - 659
  • [3] Rectal diclofenac for prevention of post-endoscopic retrograde cholangiography pancreatitis
    Losada, Hector F.
    San Martin, Pablo, I
    Troncoso, Andres, I
    Silva, Jorge A.
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (02) : 1336 - 1341
  • [4] The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Okuno, Mitsuru
    Shiroko, Junko
    Taguchi, Daisuke
    Yamaguchi, Kimihiro
    Takada, Jun
    Imai, Susumu
    Sato, Hiroyuki
    Thanabashi, Shinobu
    INTERNAL MEDICINE, 2018, 57 (16) : 2289 - 2294
  • [5] Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial
    Otsuka, Taiga
    Kawazoe, Seiji
    Nakashita, Shunya
    Kamachi, Saori
    Oeda, Satoshi
    Sumida, Chinatsu
    Akiyama, Takumi
    Ario, Keisuke
    Fujimoto, Masaru
    Tabuchi, Masanobu
    Noda, Takahiro
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (08) : 912 - 917
  • [6] Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial
    Taiga Otsuka
    Seiji Kawazoe
    Shunya Nakashita
    Saori Kamachi
    Satoshi Oeda
    Chinatsu Sumida
    Takumi Akiyama
    Keisuke Ario
    Masaru Fujimoto
    Masanobu Tabuchi
    Takahiro Noda
    Journal of Gastroenterology, 2012, 47 : 912 - 917
  • [7] Risk Factors for Post Endoscopic Retrograde Cholangio Pancreatography(ERCP) Pancreatitis (PEP) and Efficacy of Octreotide in its Prevention
    Aleem, Abdul
    Sarwar, Shahid
    Mahmud, Yasir
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2022, 28 (04): : 387 - 392
  • [8] Celecoxib Oral Administration for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Randomized Prospective Trial
    Kato, Kunihiro
    Shiba, Masatsugu
    Kakiya, Yuki
    Maruyama, Hirotsugu
    Ominami, Masaki
    Fukunaga, Shusei
    Sugimori, Satoshi
    Nagami, Yasuaki
    Watanabe, Toshio
    Tominaga, Kazunari
    Fujiwara, Yasuhiro
    PANCREAS, 2017, 46 (07) : 880 - 886
  • [9] Magnetic resonance cholangio-pancreatography versus endoscopic retrograde cholangio-pancreatography in the diagnosis of common bile duct stones: a prospective comparative study
    Scaffidi, M. G.
    Luigiano, C.
    Consolo, P.
    Pellicano, R.
    Giacobbe, G.
    Gaeta, M.
    Blandino, A.
    Familiari, L.
    MINERVA MEDICA, 2009, 100 (05) : 341 - 347
  • [10] Effect of body weight on fixed dose of diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Leerhoy, Bonna
    Nordholm-Carstensen, Andreas
    Novovic, Srdan
    Hansen, Mark Berner
    Jorgensen, Lars Nannestad
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (08) : 1007 - 1012